Tempest Therapeutics (TPST) Asset Utilization Ratio (2015 - 2018)
Tempest Therapeutics' (TPST) quarterly Asset Utilization Ratio came in at 0.01 in Q3 2018, up 52.36% year-over-year from 0.0 in Q3 2017, and up 12.78% quarter-over-quarter from 0.0 in Q2 2018.
Analysis
Tempest Therapeutics (TPST) Asset Utilization Ratio (2015 - 2018) Analysis & Trends
Tempest Therapeutics has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.01 for Q3 2018.
- In Q3 2018, Asset Utilization Ratio rose 52.36% year-over-year to 0.01; the TTM figure through Sep 2018 stood at 0.01 (up 52.36% YoY), while the FY2017 annual figure was 0.0, down 36.41% from the prior year.
- Asset Utilization Ratio came in at 0.01 for Q3 2018 at Tempest Therapeutics, up from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q3 2018 to a low of 0.0 in Q1 2015.
- Average Asset Utilization Ratio over 4 years is 0.0, with a median of 0.0 recorded in 2017.
- Year-over-year, Asset Utilization Ratio surged 2418.36% in 2016 and retreated 19.5% in 2017.
- Over 4 years, Asset Utilization Ratio stood at 0.0 in 2015, then soared by 159.3% to 0.0 in 2016, then slipped by 17.75% to 0.0 in 2017, then soared by 38.43% to 0.01 in 2018.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.01 in Q3 2018, 0.0 in Q2 2018, and 0.0 in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 0.30 |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 0.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 0.35 |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 0.76 |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 0.02 |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | 0.11 |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 0.55 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 0.62 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 0.62 |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 0.00 |
| Dec 31, 2017 | 0.00 |
| Sep 30, 2017 | 0.00 |
| Jun 30, 2017 | 0.00 |
| Mar 31, 2017 | 0.00 |
| Dec 31, 2016 | 0.00 |
| Sep 30, 2016 | 0.00 |
| Jun 30, 2016 | 0.00 |
| Mar 31, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | 0.00 |